Xinhuan Su

766 total citations
12 papers, 551 citations indexed

About

Xinhuan Su is a scholar working on Molecular Biology, Physiology and Infectious Diseases. According to data from OpenAlex, Xinhuan Su has authored 12 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Physiology and 2 papers in Infectious Diseases. Recurrent topics in Xinhuan Su's work include Gut microbiota and health (8 papers), Diet and metabolism studies (3 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Xinhuan Su is often cited by papers focused on Gut microbiota and health (8 papers), Diet and metabolism studies (3 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Xinhuan Su collaborates with scholars based in China and United States. Xinhuan Su's co-authors include Qunye Zhang, Yang Li, Zhe Wang, Xianlun Yin, Xiaowei Wang, Shucui Zhang, Xuefang Yan, Shizhan Ma, Zhe Wang and Ying Zhao and has published in prestigious journals such as Circulation Research, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Xinhuan Su

10 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinhuan Su China 8 383 222 71 69 58 12 551
Yik Wen Loh Australia 7 270 0.7× 155 0.7× 40 0.6× 55 0.8× 46 0.8× 10 481
Yee Kwan Chan Canada 12 335 0.9× 181 0.8× 36 0.5× 29 0.4× 34 0.6× 18 605
Mohammed A. I. Al-Obaide United States 9 320 0.8× 191 0.9× 31 0.4× 24 0.3× 42 0.7× 18 463
Kati Kaartinen Finland 10 202 0.5× 167 0.8× 46 0.6× 57 0.8× 23 0.4× 24 606
Mari Mizuno Japan 12 224 0.6× 112 0.5× 44 0.6× 81 1.2× 33 0.6× 40 604
Lucas Massier Sweden 11 440 1.1× 387 1.7× 66 0.9× 67 1.0× 49 0.8× 24 831
Ieva Strēle Latvia 11 202 0.5× 154 0.7× 103 1.5× 96 1.4× 32 0.6× 22 497
Lingjuan Jiang China 11 387 1.0× 272 1.2× 53 0.7× 21 0.3× 64 1.1× 18 689
Bibin Yesodha Subramanian Switzerland 6 202 0.5× 117 0.5× 36 0.5× 58 0.8× 27 0.5× 7 498
L. Framarin Italy 10 180 0.5× 109 0.5× 89 1.3× 101 1.5× 35 0.6× 15 469

Countries citing papers authored by Xinhuan Su

Since Specialization
Citations

This map shows the geographic impact of Xinhuan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinhuan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinhuan Su more than expected).

Fields of papers citing papers by Xinhuan Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinhuan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinhuan Su. The network helps show where Xinhuan Su may publish in the future.

Co-authorship network of co-authors of Xinhuan Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xinhuan Su. A scholar is included among the top collaborators of Xinhuan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinhuan Su. Xinhuan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Su, Xinhuan, et al.. (2025). Effects of high-dose glucocorticoids on gut microbiota in the treatment of Graves’ ophthalmopathy. Microbiology Spectrum. 13(6). e0246724–e0246724.
3.
Liu, Shudong, Fengxia Zhang, Xinhuan Su, et al.. (2023). The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP/PS1 mice. Journal of Translational Medicine. 21(1). 657–657. 7 indexed citations
4.
5.
Yin, Xianlun, Junfeng Ge, Xinhuan Su, et al.. (2021). MiR‐363‐5p modulates regulatory T cells through STAT4‐HSPB1‐Notch1 axis and is associated with the immunological abnormality in Graves' disease. Journal of Cellular and Molecular Medicine. 25(19). 9364–9377. 4 indexed citations
6.
7.
Chen, Bin, Zhe Wang, Jingwen Wang, et al.. (2020). The oral microbiome profile and biomarker in Chinese type 2 diabetes mellitus patients. Endocrine. 68(3). 564–572. 46 indexed citations
8.
Li, Yang, Xinhuan Su, Ying Gao, et al.. (2020). The potential role of the gut microbiota in modulating renal function in experimental diabetic nephropathy murine models established in same environment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(6). 165764–165764. 67 indexed citations
9.
Su, Xinhuan, Xianlun Yin, Yue Liu, et al.. (2020). Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves’ Disease Patients by Propionic Acid. The Journal of Clinical Endocrinology & Metabolism. 105(11). 3526–3547. 101 indexed citations
10.
Yan, Xuefang, Jiajia Jin, Xinhuan Su, et al.. (2020). Intestinal Flora Modulates Blood Pressure by Regulating the Synthesis of Intestinal-Derived Corticosterone in High Salt-Induced Hypertension. Circulation Research. 126(7). 839–853. 166 indexed citations
11.
Su, Xinhuan, Ying Zhao, Yang Li, Shizhan Ma, & Zhe Wang. (2020). Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis. Clinical Science. 134(12). 1521–1535. 85 indexed citations
12.
Li, Yang, Xinhuan Su, Lei Zhang, et al.. (2019). Dysbiosis of the gut microbiome is associated with CKD5 and correlated with clinical indices of the disease: a case–controlled study. Journal of Translational Medicine. 17(1). 228–228. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yik Wen Loh Breakdown of academic impact, for papers by Yee Kwan Chan Breakdown of academic impact, for papers by Mohammed A. I. Al-Obaide Breakdown of academic impact, for papers by Kati Kaartinen Breakdown of academic impact, for papers by Mari Mizuno Breakdown of academic impact, for papers by Lucas Massier Breakdown of academic impact, for papers by Ieva Strēle Breakdown of academic impact, for papers by Lingjuan Jiang Breakdown of academic impact, for papers by Bibin Yesodha Subramanian Breakdown of academic impact, for papers by L. Framarin
Rankless by CCL
2026